ArticleAtencion primaria2011
[Adverse effects of the human papillomavirus vaccine].
Article in Atencion primaria, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- Health care informational challenges for women diagnosed with cervical intraepithelial neoplasia: a qualitative study.BMC women's health · 2019Article
- [Safety of the papillomavirus vaccine].Atencion primaria · 2011Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo describe the most frequent adverse reactions produced by the human papillomavirus (HPV) vaccine.
designCross-sectional descriptive study using a telephone survey.
settingA province in the Andalusian Public Health System.
participantsFemales vaccinated against HPV in Andalusia, selected by simple random sampling representative of the province. MAIN MEASUREMENTS: A total of 3,135 telephone calls were made by the public service "Health Answers" using telephone operators supervised by health personnel.
resultsOf the 2,880 calls that fulfilled the inclusion criteria, 1,207 people (41.9% response) took part in the survey. Of the 2,124 surveys made there was some type of adverse reaction (fever, inflammation, pain or rash) in 467 doses (22%): 6.6% was fever, 49.5% inflammation, 72.4% pain, and 6% a rash.
conclusionsIt can be said that HPV vaccine is safe, which is in agreement with that published in the summary of the product characteristics and in the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.